Oct 10, 2026 10:55AM
Sep 26, 2026 10:28AM
Mar 4, 2024 08:01AM
Apr 26, 2022 07:17AM
Apr 26, 2022 07:15AM
May 3, 2021 04:58PM
May 3, 2021 04:32PM Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights
Mar 10, 2021 04:28PM
Mar 10, 2021 04:00PM
Jan 15, 2021 05:56AM
Jan 4, 2021 07:00AM
Dec 17, 2020 07:00AM
Dec 15, 2020 07:06AM
Dec 15, 2020 07:00AM Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier Permeability for Drug Candidate LP-184 in Glioblastoma and Potentially Other CNS Cancers
Nov 24, 2020 07:30AM
Oct 29, 2020 03:59PM
Oct 22, 2020 07:00AM
Oct 5, 2020 07:59AM
Oct 5, 2020 07:46AM
Sep 22, 2020 07:56AM
Sep 22, 2020 07:55AM Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer
Aug 27, 2020 07:55AM
Aug 14, 2020 02:25PM
Jul 30, 2020 07:43AM
Jul 30, 2020 06:57AM
Jul 24, 2020 07:56AM
Jun 29, 2020 08:45AM
Jun 17, 2020 09:23AM Lantern Pharma Announces Two Presentations at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting
Jun 17, 2020 09:23AM
Jun 15, 2020 03:53PM

127,545 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All